ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,267Medicare Part D Prescriptions Filled, Including Refills

Rank: 128 out of 337

$478K Total Retail Price of All Prescriptions

Rank: 84 out of 337

290 Patients Receiving at Least One Drug in Part D
69%Patients 65 Years and Older
88% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Rhode Island
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 290 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

18% of this provider’s 290 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 5,013 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$66 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
AMLODIPINE BESYLATE 300 264 1 3
OMEPRAZOLE 287 202 2 4
HYDROCODONE-ACETAMINOPHEN 236 102 S3 3 13
METFORMIN HCL 223 151 4 12
METOPROLOL TARTRATE 185 145 5 6
LISINOPRIL 182 125 6 2
SIMVASTATIN 181 147 7 1
ALENDRONATE SODIUM 172 151 8 19
METOPROLOL SUCCINATE 152 115 9 21
LOSARTAN POTASSIUM 145 122 10 15
GABAPENTIN 145 55 10 20
ZOLPIDEM TARTRATE 144 83 12 23
PRAVASTATIN SODIUM 141 98 13 14
IBUPROFEN 132 89 14 64
HYDROCHLOROTHIAZIDE 131 91 15 9
ATENOLOL 127 109 16 10
CRESTOR 119 97 17 29
LEVOTHYROXINE SODIUM 111 63 18 5
GLIMEPIRIDE 107 70 19 55
ATORVASTATIN CALCIUM 101 84 20 7
SERTRALINE HCL 101 78 20 18
FLUTICASONE PROPIONATE 98 64 22 34
LOSARTAN-HYDROCHLOROTHIAZIDE 93 71 23 60
RANITIDINE HCL 82 41 24 30
VENTOLIN HFA 77 58 25 159
SINGULAIR 77 44 25 113
ADVAIR DISKUS 76 64 27 44
PROAIR HFA 75 48 28 38
OXYCODONE HCL 63 21 S2 29 63
TRAZODONE HCL 63 17 29 16
LISINOPRIL-HYDROCHLOROTHIAZIDE 62 62 31 31
MECLIZINE HCL 61 48 32 117
CELEBREX 59 29 33 116
SPIRIVA 52 41 34 43
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 28, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.